VIVS VIVOSIM LAB

$0.32

VIVOSIM LAB (VIVS) is expected to report earnings on November 11, 2026, before the market open.

VIVOSIM LAB Reported Earnings
Wednesday, August 12, 2026 · 12:00 AM ET
Earnings Date
Nov 11
Wednesday · Before Open
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About VIVOSIM LAB

VivoSim Labs Inc. is a clinical-stage biotechnology company. It involved in developing drugs which are demonstrated to be effective in three-dimensional human tissues as candidates for drug development. The company focuses on developing novel treatment approaches in inflammatory bowel disease. VivoSim Labs Inc., formerly known as Organovo Holdings Inc., is based in SAN DIEGO, United States.